Please provide your email address to receive an email when new articles are posted on . A group of experts updated the FITTER insulin injection recommendations for the first time since 2016.

from syringes to insulin pens, to an insulin pump, or even with an inhaler. Maintaining blood glucose levels helps reduce the risk of diabetes complications, such as blindness and the loss of limbs.

In a major breakthrough for diabetes treatment, scientists have found a new way to regenerate insulin-producing cells. This approach could change how type 1 diabetes is treated, moving beyond just ...

India’s diabetic population, particularly those on Novo Nordisk ... Besides by market capitalization, Novo Nordisk is largest in Denmark. Pen insulin range of Novo Nordisk is convenient, accurate, not ...

Receiving FDA clearance would allow Medtronic to pair its pumps with a glucose monitor being developed for the company by ...

Medtronic announced today that it submitted 510(k) applications to the FDA seeking clearance for an interoperable insulin ...

Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time.

After years of preparation, Eli Lilly is on the brink of launching a fully connected and personalised diabetes management ... brings together a pre-filled insulin pen, the TempoSmart app and ...

This dynamic sector, marked by innovation and technological prowess, witnesses a paradigm shift in the way individuals with diabetes navigate their daily lives. At its core, the Insulin Pump serves as ...

Taking insulin ... diabetes with insulin. Clinical guidelines recommend that you rotate the spots where you inject insulin. This applies to injecting insulin with a syringe, prefilled insulin pen ...

The mission marks a groundbreaking attempt to explore how astronauts with diabetes might one day participate ... whether commercially available insulin pens remain effective in space, as ...

Thirty-seven-year-old Nupur Lalvani, who has been living with Type 1 diabetes since the age of eight, was dependent on insulin pens and had of late been a regular user of Novo Nordisk’s largest ...